November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Vivek Subbiah: The 3rd KRAS G12C kid on the block.
Aug 27, 2023, 18:58

Vivek Subbiah: The 3rd KRAS G12C kid on the block.

According to Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute:
“Just published NEJM – the 3rd KRAS G12C kid on the block. Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation.
NSCLC, ORR= 53.4%  
mPFS = 13.1 months  
Colorectal cancer= 29.1%  
mPFS= 5.6 months”
For the article click here.
Source: Vivek Subbiah/Twitter